Bradykinin-induced release of nitric oxide by the isolated perfused rat heart: Importance of preformed pools of nitric oxide-containing factors

Journal of Hypertension

Volumn 16, Issue 2, 1998, Pages 239-244

  Danser, A H Jan ^a   De Vries, René ^a   Schoemaker, Regien G ^a   Saxena, Pramod R ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Bradykinin; L arginine; Langendorff heart; N( ) nitro L arginine methyl ester; Nitric oxide

Indexed keywords

ARGININE; ARGININE METHYL ESTER; BRADYKININ; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; DOWN REGULATION; ENZYME INHIBITION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

EID: 0031932520     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816020-00015     Document Type: Article

References (14)

1. Mombouli J-V, Illiano S, Nagao T, Scott-Burden T, Vanhoutte PM. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ Res 1992; 71:137-144.
2. Palmer RMJ, Rees DD, Ashton DS, Moncada S. L-Arginme is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 1988; 153:1251-1256.
3. Rees DD, Palmer RM, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101:746-752.
4. 2 in the nitric oxide-independent vasodilator effect of bradykinin in the rat perfused heart. J Pharmacol Exp Ther 1996; 278:518-526.
5. G-nitro-L-arginine methyl ester. Br J Pharmacol 1990; 101:632-639.
6. Bjornstad-Ostensen A, Holte HR, Berg T. Amplification of kinin-induced hypotension by nitric oxide synthesis in spontaneously hypertensive rats. Hypertension 1997; 29:53-57.
7. Ignarro LJ. Nitric oxide: a novel transduction mechanism for transcellular communication. Hypertension 1990; 16:477-483.
8. Davisson RL, Bates JN, Johnson K, Lewis SJ. Use-dependent loss of acetylcholine- and bradykinin-mediated vasodilation after nitric oxide synthase inhibition. Evidence for preformed stores of nitric oxide-containing factors in vascular endothelial cells. Hypertension 1996; 28:354-360.
9. Buga GM, Griscavage JM, Rogers NE, Ignarro LJ. Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res 1993; 73:808-812.
10. Rogers NE, Ignarro LJ. Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochem Biophys Res Commun 1992; 189:242-249.
11. Feelisch M. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J Cardiovasc Pharmacol 1991; 17 (suppl 3):S25-S33.
12. Assreuy J, Cunha FQ, Liew FY, Moncada S. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol 1993; 108:833-837.
13. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993; 92:652-655.
14. Hirooka Y, Imaizumi T, Ando S-I, Harada S, Momohara M, Takeshita A. Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients. Hypertension 1992; 20:175-180.